Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Floor J Backes

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|October 5, 2011
Endometrial cancer patients and compliance with genetic counseling: room for improvementFloor J Backes, Elizabeth Mitchell, Heather Hampel, et al.
JAMA Network Open|December 7, 2023
Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic CancerWafa Khadraoui, Caitlin E Meade, Floor J Backes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 15, 2011
The impact of body weight on ovarian cancer outcomesFloor J Backes, Christa I Nagel, Elizabeth Bussewitz, et al.
Gynecologic Oncology Reports|April 17, 2023
Combination lenvatinib plus pembrolizumab in the treatment of ovarian clear cell carcinoma: A case seriesCorinne A Calo, Monica D Levine, Morgan D Brown, et al.
Gynecologic Oncology|June 15, 2023
The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteriaPaulina J Haight, Courtney J Riedinger, Floor J Backes, et al.
Journal of Minimally Invasive Gynecology|June 4, 2014
Training the next generation of robotic surgeons using guided mentorship: a randomized controlled trialMargaret I Liang, Georgia A McCann, Kellie S Rath, et al.
Cancer|December 19, 2018
Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarkerFloor J Backes, Jennifer Haag, Casey M Cosgrove, et al.
International Journal of Cancer|August 10, 2018
Functional characterization of recurrent FOXA2 mutations seen in endometrial cancersRobert Neff, Craig M Rush, Blair Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 17, 2018
The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case SeriesMichelle C Nguyen, Manisha H Shah, David A Liebner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2015
Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and PrognosisAmy S Joehlin-Price, Julie A Stephens, Jianying Zhang, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|October 5, 2011
Endometrial cancer patients and compliance with genetic counseling: room for improvementFloor J Backes, Elizabeth Mitchell, Heather Hampel, et al.
JAMA Network Open|December 7, 2023
Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic CancerWafa Khadraoui, Caitlin E Meade, Floor J Backes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 15, 2011
The impact of body weight on ovarian cancer outcomesFloor J Backes, Christa I Nagel, Elizabeth Bussewitz, et al.
Gynecologic Oncology Reports|April 17, 2023
Combination lenvatinib plus pembrolizumab in the treatment of ovarian clear cell carcinoma: A case seriesCorinne A Calo, Monica D Levine, Morgan D Brown, et al.
Gynecologic Oncology|June 15, 2023
The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteriaPaulina J Haight, Courtney J Riedinger, Floor J Backes, et al.
Journal of Minimally Invasive Gynecology|June 4, 2014
Training the next generation of robotic surgeons using guided mentorship: a randomized controlled trialMargaret I Liang, Georgia A McCann, Kellie S Rath, et al.
Cancer|December 19, 2018
Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarkerFloor J Backes, Jennifer Haag, Casey M Cosgrove, et al.
International Journal of Cancer|August 10, 2018
Functional characterization of recurrent FOXA2 mutations seen in endometrial cancersRobert Neff, Craig M Rush, Blair Smith, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 17, 2018
The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case SeriesMichelle C Nguyen, Manisha H Shah, David A Liebner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2015
Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and PrognosisAmy S Joehlin-Price, Julie A Stephens, Jianying Zhang, et al.
Pageof 11